Stay updated with breaking news from Nuclear Export. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedicated to...
Karyopharm Announces Further Transition of Co-Founders Sharon Shacham PhD, MBA and Michael Kauffman, MD, PhD and appointment of Reshma Rangwala, MD, PhD as Chief Medical Officer - read this article along with other careers information, tips and advice on BioSpace
/PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced the...
Shares of Karyopharm Therapeutics Inc. (NASDAQ:KPTI – Get Rating) have been assigned a consensus recommendation of “Hold” from the eight research firms that are currently covering the firm, MarketBeat.com reports. Six analysts have rated the stock with a hold rating and two have given a buy rating to the company. The average twelve-month target price […]
Karyopharm Therapeutics (NASDAQ:KPTI – Get Rating) had its price objective trimmed by HC Wainwright from $23.00 to $22.00 in a research report report published on Friday morning, MarketBeat reports. The firm currently has a buy rating on the stock. Several other equities analysts have also weighed in on the stock. SVB Leerink cut their price […]